Phio Pharmaceuticals Corp.

NasdaqCM:PHIO Stock Report

Mkt Cap: US$7.2m

Phio Pharmaceuticals Financial Health

How is Phio Pharmaceuticals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: PHIO's short term assets ($15.4M) exceed its short term liabilities ($2.2M).

Long Term Liabilities: PHIO's short term assets ($15.4M) exceed its long term liabilities ($70.0K).


Debt to Equity History and Analysis

Debt Level: PHIO is debt free.

Reducing Debt: PHIO had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PHIO has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PHIO has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 7.4% each year.


Discover healthy companies